Drug Guide
Mestranol and Norethynodrel
Classification
Therapeutic: Contraceptive, hormone hormone combination
Pharmacological: Estrogen and progestin combination
FDA Approved Indications
- Oral contraception
Mechanism of Action
Mestranol is a prodrug of ethinylestradiol (estrogen), which suppresses ovulation by feedback inhibition of the hypothalamus and pituitary, reducing gonadotropin release. Norethynodrel is a progestin that also suppresses ovulation, alters cervical mucus making it less penetrable to sperm, and changes the endometrial lining to prevent implantation.
Dosage and Administration
Adult: Typically, one tablet daily for 21 or 28 days as directed by the physician.
Pediatric: Not indicated for pediatric use.
Geriatric: Not specifically indicated for geriatric population.
Renal Impairment: Adjustments not well established; use with caution.
Hepatic Impairment: Use is contraindicated or caution advised due to hepatic metabolism.
Pharmacokinetics
Absorption: Well absorbed from gastrointestinal tract.
Distribution: Plasma protein binding varies by component.
Metabolism: Extensively metabolized in the liver via conjugation and hydroxylation.
Excretion: Excreted primarily in urine and feces.
Half Life: Mestranol has a half-life of approximately 2-4 hours, norethynodrel approximately 24 hours.
Contraindications
- History of thromboembolic disorders
- Estrogen-dependent neoplasia
- Abnormal vaginal bleeding of unknown cause
- Pregnancy
Precautions
- History of migraines, smoking, liver disease, hypertension, diabetes, or gallbladder disease.
Adverse Reactions - Common
- Nausea or vomiting (Common)
- Breast tenderness (Common)
- Headache (Common)
- Weight gain (Less common)
Adverse Reactions - Serious
- Deep vein thrombosis (DVT) (Serious/perhaps rare)
- Myocardial infarction (Serious)
- Stroke (Serious)
- Hypertension (Less common)
- Liver tumors (Rare)
Drug-Drug Interactions
- Antibiotics such as penicillins, tetracyclines which may reduce contraceptive effectiveness
- Anticonvulsants like phenytoin, phenobarbital, carbamazepine
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Assess for contraindications, pregnancy status, and compliance.
Diagnoses:
- Risk for ineffective contraception
- Risk for thrombosis
Implementation: Advise patient to take medication at the same time daily, preferably with food to reduce gastrointestinal upset.
Evaluation: Monitor for signs of pregnancy or adverse effects; assess compliance regularly.
Patient/Family Teaching
- Instruct on proper use, missed dose instructions, and importance of daily intake.
- Warn about side effects, especially signs of thromboembolic events.
- Advise on using additional contraceptive methods if gastrointestinal disturbances occur.
Special Considerations
Black Box Warnings:
- Increased risk of blood clots, stroke, and myocardial infarction, especially in women over 35 who smoke.
Genetic Factors: Genetic variations may influence drug metabolism.
Lab Test Interference: May affect hepatic function tests, coagulation studies, or lipid profiles.
Overdose Management
Signs/Symptoms: Nausea, vomiting, dizziness, or unexpected vaginal bleeding.
Treatment: Supportive care, symptomatic treatment, and gastric lavage if ingestion was recent.
Storage and Handling
Storage: Store at room temperature, away from heat and moisture.
Stability: Stable when stored properly for the duration of labeled shelf life.